• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Cessation Therapeutics Presents Findings From Anti-Fentanyl Study

    BUSINESSWIRE

    Cessation Therapeutics Receives FDA Fast Track Designation for CSX-1004

    BUSINESSWIRE

    Cessation Awarded $14.8 Million Grant from the National Institute of Drug Abuse

    BUSINESSWIRE

    Dr. Vince Clinical Research Joins the Fight Against the Fentanyl Crisis, Announces Screening of First Subject for Cessation Therapeutics’ Overdose Prevention Therapy in a First-In-Human Trial

    BUSINESSWIRE

    Cessation Announces FDA Authorization for First-in-Human Trial of Antibody

    BUSINESSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.